New antibody shows promise for thyroid eye disease in early trial
Disease control
Completed
This study tested a new drug called LASN01 in 41 adults with moderate-to-severe thyroid eye disease, a condition that causes eye bulging and discomfort. The drug aims to reduce eye bulging and inflammation by blocking a specific receptor. Participants received either LASN01 or a …
Phase: PHASE2 • Sponsor: Lassen Therapeutics Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC